Atherosclerosis progression was more than twice as common in younger people with systemic lupus erythematosus (SLE) than in ...

Lupus warriors were treated to a makeup tutorial and demo, which aimed to uplift and empower them to continue to shine ...

Legendary R&B singer Eddie Levert is mourning the loss of his daughter, Ryan Levert. The O’Jays singer’s grandchildren, ...

Scientists at the Oklahoma Medical Research Foundation are one step closer to determining the genetic trigger for lupus in ...

A new study explored the potential of IncRNA CASC2 and miR-155 levels as non-invasive diagnostic biomarkers for systemic lupus erythematosus (SLE) and lupus nephritis (LN). Previous studies have found ...

A-319 is under clinical development by ITabMed and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase I drugs for Systemic Lupus Erythematosus have a 73% phase ...

Cori Broadus shares her journey through a recent stroke and recovery, revealing the dangers of stopping medication cold turkey.

Felzartamab is under clinical development by Biogen and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition success rate ...

An analysis of 2024 Google search data revealed the top health questions asked by Americans. A registered nurse provides ...

If reading about these atrocities churns your stomach, reflect on what is going on before our eyes these very days ...

Now, scientists at Stanford University have found that a faulty genetic molecule could be responsible for the immune system misidentifying healthy tissue as a threat. The breakthrough study, published ...

In a new study published in Lupus Science & Medicine, researchers explored the efficacy of using a combination of belimumab and standard immunotherapy compared to standard immunotherapy alone in ...